UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C. 20549

                              FORM 10-KSB
[X]  Annual Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

               FOR THE YEAR ENDED DECEMBER 31, 2001
                Commission File Number 0-31547

                         DrGoodTeeth.com
        -----------------------------------------------
     (Exact name of registrant as specified in its charter)

        Nevada                             88-0451554
-------------------------------            -----------
(State or other jurisdiction of          (I.R.S. Employer
 incorporation or organization)          Identification No.)

280 Madison Ave., Ste. 1110-211
       New York, NY 				     10016
---------------------------------------     -----------
(Address of principal executive offices)    (Zip Code)

Registrant's telephone number, including area code:
(212) 386-5695

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:
Common Stock, par value $.001 per share

Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months,
and (2) has been subject to such filing requirements for the
past 90 days.  YES: [X] NO: [ ]

Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not contained herein,
and will not be contained, to the best of registrant's
knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form
10-K or any amendment to this Form 10-K. [X]

The number of shares outstanding of the registrant's common
stock as of December 31, 2001 was 4,000,000.

Registrant had no revenues for its year ended December 31, 2001.

Registrant's common stock is listed on the OTCBB under the
symbol "DRGT".

                               1


                               PART I

ITEM 1.      DESCRIPTION OF BUSINESS

DrGoodTeeth.com, (the "Company") was incorporated in the State
of Nevada on February 15, 2000. The Company was formed to engage
in the business of operating an online dental resource website.

Registrant is authorized to issue up to 100,000,000 (One Hundred
Million) shares of common stock, par value $.001.

Though in its developmental stage, Registrant operates an
Internet-based consumer dental network. The network consists of
a consumer-focused interactive website, which provides users
with comprehensive dental related information and services.  The
website, www.DrGoodTeeth.com, is a dental resource which
integrates dynamic dental related content, an
interactive community and tools. Registrant's objective is to
establish the DrGoodTeeth.com network as one of the most trusted
and comprehensive sources of consumer dental-related information
and services on the Internet.

The Company's network will provide consumers with a variety of
dental-related content, including information on all disciplines
of dentistry, definitions, conditions, links to suppliers and
educational facilities and current news articles.  The customer
support group/chat room will allow
users to share experiences with others who face, or have faced,
similar dental conditions, leveraging the aggregate community to
benefit each member.  The website will also provide interactive
tools that permit users to personalize their DrGoodTeeth.com
experience and is currently developing additional features to
expand the functionality of the website based on user feedback.

There have been no bankruptcy, receiverships, or similar
proceedings by or against Registrant.  There has been no
material reclassification, merger, consolidation, or purchase or
sale of any significant asset(s).

As of the date of this filing, Registrant is still in its
developmental stage and has not yet commenced full business
operations or realized any revenues.

As of December 31, 2000, Registrant had no employees other than
its officers and directors, none of which are represented by a
collective bargaining agreement.

ITEM 2.  DESCRIPTION OF PROPERTY

Registrant currently maintains a mailing address and answering
service in New York at 280 Madison Avenue, Suite 1110-211, New
York, New York 10016, for which it pays a competitive monthly
rate.  Registrant owns no property other than its software,
domain name and proprietary data.

                                  2
ITEM 3.  LEGAL PROCEEDINGS

Registrant is not a party to any legal proceedings.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

There were no matters submitted to a vote of security holders
during the fourth quarter of the fiscal year ended December 31,
2001.

                             PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Registrant's common stock is listed on the OTCBB pursuant to
NASD Rule 6740 and Rule 15c2-11 under the Securities Exchange
Act of 1934 under the symbol "DRGT".

As of the date of filing this Registration Statement there has
been very limited trading of and no market for the common stock;
the current bid/ask prices are $1.26/$10.25, with no sales or
volume; the last sale was in July 2001 and only a total of
16,000 shares have sold since commencement of trading in May
2001.

To date, Registrant has issued 4,000,000 shares of its Common
Stock. These include the 2,000,000 shares issued to the founders
of the Company, and 2,000,000 shares in a public offering
pursuant to an exemption provided by Rule 504 of Regulation D,
promulgated under the Securities Act of 1933, as amended, and
which were purchased and are held by 36 shareholders, none of
which hold more than 5% of the shares outstanding or are related
to the officers or directors of Registrant.

ITEM 6.  SELECTED FINANCIAL DATA

The following selected financial data was derived from
Registrant's audited Financial Statements. The information set
forth below should be read in conjunction with Registrant's
Financial Statements and related Notes included elsewhere in
this report.

<TABLE><CAPTION>
Year Ended December 31, 2001
----------------------------
<S>                                            <C>
STATEMENT OF OPERATIONS DATA:

Net revenues                                    0
Net income (loss)                         $ (3,656)
Basic income (loss) per share                (.001)
Weighted average shares outstanding      4,000,000
</TABLE>

                                     3

<TABLE><CAPTION>

BALANCE SHEET DATA:
<S>                                          <C>
Cash and cash equivalents                $   88,919
Total assets                                 88,919
Long-term debt                                    0
Stockholders' equity                         88,919
</TABLE>

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS
---------------------

Registrant has not yet commenced full business operations or
realized any revenues.

Registrant had a net loss of $3,656 at December 31, 2001,
resulting in a net loss per share of $.001.

General and administrative expenses at December 31, 2001 were
$3,656, consisting of professional fees in the amount of $950
and operating expenses in the amount of $2,706.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

At December 31, 2001, Registrant's primary sources of liquidity
included cash and cash equivalents of $88,919, which was the
balance of proceeds raised in Registrant's initial public
offering conducted in the State of Nevada, pursuant to Rule 504
of Regulation D.

Registrant believes that its existing cash balance and future
operating cash flows will be sufficient for near term operating
needs. The extent to which such sources will be sufficient to
meet Registrant's anticipated cash requirements is subject to a
number of uncertainties, the most important of which is
Registrant's ability  to generate sufficient cash flow to
support its proposed business operations.

UNCERTAINTIES RELATING TO FORWARD-LOOKING STATEMENTS
----------------------------------------------------
Certain parts of this Form 10-KSB may contain "forward-looking
statements" within the meaning of the Securities Exchange Act of
1934, as amended, based on current management expectations.
Actual results could differ
materially from those in the forward-looking statements due to a
number of uncertainties, including, but not limited to, those
discussed in this section. Factors that could cause future
results to differ from these expectations include general
economic conditions particularly related to demand for

                               4

Registrant's services; changes in business strategy; competitive
factors (including the introduction or enhancement of
competitive services); pricing pressures; changes in operating
expenses; inability to attract or retain consulting, sales
and/or development talent; changes in customer requirements;
and/or evolving industry standards.

ITEM 8.      FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Registrant's financial statements for the year ended December
31, 2001, prepared and audited by Clyde Bailey, P.C.,
independent chartered accountant is included herein.

ITEM 8.       CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE.  None.

                           PART III

ITEM 9.      DIRECTORS AND EXECUTIVE OFFICERS OF REGISTRANT.

Each of Registrant's directors is elected by the stockholders to
a term of one year and serves until his or her successor is
elected and qualified. Each of the officers  is  elected  by the
Board of Directors to a term of one year and serves until his or
her successor is duly elected and qualified, or until he or she
is removed from office. The Board of Directors has no
nominating, auditing or compensation  committees.

The names, addresses, ages and positions of the current officers
and directors is set  forth  below:
<TABLE><CAPTION>
<S>                               <C>    <C>
Name and Address                  Age    Position(s)
----------------                 ----    -------------
Dr. Anchana Chayawatana           26     President,
295/42 Ngarmwongwan 23 Road              Secretary and
Nonthaburi 11000 Thailand                Director

Lt. Dr. Somdul Manpiankarn        27     Treasurer and
237/466 Soi Saitong                      Director
Tiwanon Road
Nonthaburi 11000 Thailand

Dr. Bancha Luangaram              27     Vice President-
240/28 Charansanitwong Rd.               Marketing and
Bangkoknoi, Bangkok 10700                Director
Thailand
</TABLE>

The persons named above have held their offices/positions
since inception of our Company and are expected to hold their
offices/positions until the next annual meeting of our
stockholders.

                          5


Background of Officers and Directors
------------------------------------
Dr. Anchana Chayawatana has been President, Secretary and a
Director of Registrant since inception.  She attended Mahidol
University in Bangkok, Thailand and received a Doctor of Dental
Science degree in 1998. From April 1998 to March 2001, she was
the head of the Dental Dept. at Sri Vichai 3 Hospital in Samut
Sakorn, Thailand. From April 1998 to September 2001, she also
practiced dentistry at President Park Dental Care, a private
dental clinic. At present, she is studying for her Master of
Science Degree in Prosthetic Dentistry at Eastman Dental
Institute for Oral Health Care Sciences, University of London,
United Kingdom. Dr. Chayawatana devotes her time as needed to
Registrant's business.

Lt. Dr. Somdul Manpiankarn has been the Treasurer and a Director
of Registrant since inception.  He attended Mahidol University
in Bangkok, Thailand and received a Doctor of Dental Science
degree in 1998, and received a Certificate in Endodontics in
2001. From April 1998 to the present, he has practiced dentistry
for the Royal Thai Survey Department.  From April 1998 to the
present, he has also practiced dentistry at Rom Mai Dental
Clinic, Clinic Banglumpoo and Patra Dental Clinic, which are
private dental clinics located in Bangkok, Thailand. Dr.
Manpiankarn devotes his time as needed to Registrant's business.

Dr. Bancha Luangaram has been the Vice President and a Director
of Registrant since inception.  He attended Mahidol University
in Bangkok, Thailand and received a Doctor of Dental Science
degree in 1998. In 2001, he received his Master of Science
Degree in Prostodontic from Chulalongkorn University in Bangkok,
Thailand. From April 1998 to May 2000, he practiced dentistry at
the Public Health Canteen, Kanchanaburi Municipality in
Kanchanaburi, Thailand. At present, he is practicing dentistry
at Bangpho General Hospital and also is a consultant for Dental
Vision Company Limited, Bangkok, Thailand. Dr. Luangaram devotes
his time as needed to Registrant's business.

ITEM 11. EXECUTIVE COMPENSATION

None of Registrant's officers or directors have been compensated
for their services, either in cash or stock, and there are no
plans to compensate them in the near future, unless and until
Registrant begins to realize revenues and becomes profitable in
its business operations. As a result, no summary compensation
tables have been included herein.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT.

The following table sets forth the total number of shares owned
beneficially by each of Registrant's directors, officers and key
employees, individually and as a group, and the present owners
of 5% or more of total outstanding shares. The stockholders

                                6


listed below have direct ownership of their shares and possesses
sole voting and dispositive power with respect to the shares.

<TABLE><CAPTION>
<S>                           <C>                <C>
------------------------------------------------------------
Title of Class  Name and Address        Amount and
                of Beneficial            Nature of   Percent
                    Owner                Beneficial of Class
                                         Ownership
------------------------------------------------------------
Common Stock  Dr. Anchana Chayawatana    1,000,000(D)   25%
              295/42 Ngarmwongwan 23 Rd.
              Nonthaburi 11000 Thailand

Common Stock  Lt.Dr. Somdul Manpiankarn    500,000(D)  12.5%
              237/466 Soi Saitong
              Tiwanon Road
              Nonthaburi 11000 Thailand

Common Stock  Dr. Bancha Luangaram         500,000(D)  12.5%
              240/28 Charansanitwong Rd.
              Bangkoknoi
              Bangkok 10700 Thailand
----------------------------
All Officers and Directors as
a Group (3 persons)                      2,000,000(D)  50%
</TABLE>

*(D) = Direct Beneficial Ownership

ITEM 12.      CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

There have been no actual or proposed transactions to which
Registrant was or is to be a party to in which any Director,
Executive Officer, nominee for election as Director, security
holder, or any member of the immediate family of any of the
aforementioned had or is to have a direct or indirect material
interest.

ITEM 13.      EXHIBITS, LISTS AND REPORTS ON FORM 8-K.

(a)     Registrant's financial statement for the year ended
        December 31, 2001 is included herein.

(b)     No reports on Form 8-K have been filed during the
fourth quarter of the fiscal year ended December 31,
2001.

The following exhibits are included herein, except for the
exhibits marked with an asterisk, which are incorporated herein
by reference and can be found in Registrant's original Form
10SB12G Registration Statement, filed on September 18, 2000,
under SEC File Number 0-31547.

                                  7

<TABLE><CAPTION>
<S>                  <C>
Exhibit Number        Description
--------------        -----------
3(i) *                Articles of Incorporation
3(ii)*                Bylaws
23                    Consent of Accountant

</TABLE>









































                                 8


























                         DrGoodTeeth.Com


                        December 31, 2001











                         Clyde Bailey, P.C.
                    Certified Public Accountant
                      10924 Vance Jackson #404
                      San Antonio, Texas 78230










                               9







Clyde Bailey, P.C.
Certified Public Accountant
10924 Vance Jackson #404
San Antonio, Texas 78230
(210) 699-1287(ofc.)
(888) 699-1287(210) 691-2911(fax)

Member:
American Institute of CPA's
Texas Society of CPA's


Board of Directors
DrGoodTeeth.Com

                   INDEPENDENT AUDITOR'S REPORT

I have audited the accompanying balance sheet of DrGoodTeeth.Com
(Company), a development stage enterprise, as of December 31,
2001 and the related statement of operations, statement of
stockholders' equity, and the statement of cash flows from
February 15, 2000 (Inception) to December 31, 2001. These
financial statements are the responsibility of the Company's
management. My responsibility is to express an opinion on these
statements based on my audit.

I conducted my audit in accordance with generally accepted
auditing standards. Those standards require that I plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An
audit includes examining on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An
audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation.  I believe that my
audit provides a reasonable basis for my opinion.

The Company is a development stage enterprise, as defined in
Financial Accounting Standards Board No. 7. The Company is
devoting all of its present efforts in securing and establishing
a new business, and its planned principal operations have not
commenced, and, accordingly, no revenue has been derived during
the organizational period.

In my opinion, the financial statements referred to above
present fairly, in all material respects, the financial position
of the Company as of December 31, 2001 and the results of its
operations and its cash flows for the periods ended December 31,
2001 and 2000 and from February 15, 2000 (inception) to December
31, 2001 in conformity with  accounting principles generally
accepted in the United States.

/s/  Clyde Bailey P.C.
San Antonio, Texas
February 20, 2002
                                   10

<TABLE><CAPTION>
                               DrGoodTeeth.com
                       (A Development Stage Enterprise)
                                BALANCE SHEET
                           As of December 31, 2001

ASSETS
------
<S>                                                <C>
Current Assets
--------------
   Total Current Assets                         $   88,919
                                                 ---------
Total Assets                                        88,919
                                                 =========
LIABILITIES
-----------
Current  Liabilities
--------------------
 Accounts Payable                                      -
                                                 ---------
   Total Current Liabilities                           -
                                                 ---------
Total Liabilities                                      -

STOCKHOLDERS EQUITY
-------------------
Common Stock                                         4,000
100,000,000 authorized shares,
par value $.001, 4,000,000
shares issued and outstanding
Additional Paid-in-Capital                         101,000
Accumulated Deficit                                (16,081)
                                                 ---------
Total Stockholders' Equity                          88,919
                                                 ---------
Total liabilities and Stockholders' Equity       $  88,919
                                                 =========
</TABLE>




The accompanying notes are integral part of the consolidated
financial statements.




                                11







<TABLE><CAPTION>

                           DrGoodTeeth.Com
                  (A Development Stage Enterprise)
                       Statement of Operations
                       -----------------------

                            --------------------      From
                            For the Years Ended    Inception
                               December 31             to
                              2001	    2000        12/31/01
                            --------------------    ---------
<S>                          <C>         <C>           <C>
Revenues:
--------
Revenue                    $    -    $     -       $    -

Expenses:
--------
Professional Fees              950       6,000         6,950
Operating expenses           2,706       6,425         9,131
                           -------   ---------      ---------
Total Expenses               3,656      12,425        16,081
                           -------   ---------      ---------
Net loss from Operations    (3,656)    (12,425)      (16,081)


Provisions for Income Taxes:
----------------------------
Income Tax Benefit              -         -             -
Net Income (Loss)           (3,656)   (12,425)       (16,081)
                           =======   ========       ========

Basic and Diluted Earnings
 Per Common Share           (0.001)    (0.003)        (0.004)
                           -------   --------       --------
Weighted Average number
of Common Shares used in
per share calculations    4,000,000  4,000,000     4,000,000
                          =========  =========     =========
</TABLE>


The accompanying notes are integral part of the consolidated
financial statements.







                            12




<TABLE><CAPTION>
                         DrGoodTeeth.Com
                  (A Development Stage Enterprise)
                 Statement of Stockholders' Equity
                     As at December 31, 2001


                    $0.001 Paid-in Accumulated Stockholders'
          Shares  Par Value Capital Deficit       Equity
-----------------------------------------------------------
<S>         <C>     <C>      <C>      <C>          <C>
Balance
February
15, 20000    -    -          -          -           -

Stock
Issued  4,000,000   4,000  101,000      -        105,000

Net Income
(Loss)                             (12,425)     (12,425)
         -------------------------------------------------
Balance
December
31,
2000    4,000,000   4,000  101,000 (12,425)      92,575

Net Income
(Loss)                              (3,656)     (3,656)
         ------------------------------------------------
Balance at
December
31,
2001   4,000,000   4,000  101,000  (16,081)     88,919
        -------------------------------------------------
</TABLE>






The accompanying notes are integral part of the consolidated
financial statements.



                                 13









<TABLE><CAPTION>
                          DrGoodTeeth.Com
                  (A Development Stage Enterprise)
                      Statement of Cash Flows

                         ---------------------      From
                           For the Years Ended    Inception
                              December 31            to
                         ---------------------    12/31/01
                            2001        2000     -----------
<S>                          <C>        <C>          <C>
Cash Flows from
Operating Activities:
---------------------
Net Income (Loss)        $ (3,656)  $  (12,425)  $ (16,081)
Accounts Payable                -            -           -
                         ----------------------------------
Net Cash Provided from
 Operating Activities    $ (3,656)  $  (12,425)  $ (16,081)
                         ----------------------------------
Cash Flows from
Investing Activities
--------------------
Other Assets                    -           -           -
                       ------------------------------------
Net Cash Used in
Investing Activities            -           -           -
                       ------------------------------------
Cash Flows from
Financing Activities
--------------------
Common Stock                    -     105,000     105,000
                       ------------------------------------
Net Cash Provided from
Financing Activities            -     105,000     105,000
                       ------------------------------------
Net Increase in Cash      (3,656)      92,575      88,919

Cash Balance, Begin
Period                    92,575            -           -
                       ------------------------------------
Cash Balance, End
Period                $   88,919    $  92,575   $  88,919
                      =====================================
Supplemental
Disclosures:
  Cash Paid for
    Interest          $         -   $      -   $        -
                      =====================================
  Cash Paid for
    income taxes      $         -   $      -   $        -
                      =====================================
</TABLE>
     The accompanying notes are integral part of the
consolidated financial statements.

                               14

                        DrGoodTeeth.Com
                 Notes to Financial Statements


NOTE 1  -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

DrGoodTeeth.Com ("the Company") was incorporated under the laws
of the State of Nevada on February 15, 2000 for the purpose to
promote and carry on any lawful business for which a corporation
may be incorporated under the laws of the State of Nevada. The
company has a total of 100,000,000 authorized shares with a par
value of $.001 per share and with 4,000,000 shares issued and
outstanding as of December 31, 2001. The Company has been
inactive since inception and has little or no operating revenues
or expenses.

Development Stage Enterprise

The Company is a development stage enterprise, as defined in
Financial Accounting Standards Board No. 7. The Company is
devoting all of its present efforts in securing and establishing
a new business, and its planned principal operations have not
commenced, and, accordingly, no revenue has been derived during
the organizational period.

Federal Income Tax

The Company has adopted the provisions of Financial Accounting
Standards Board Statement No. 109, Accounting for Income Taxes.
The Company accounts for income taxes pursuant to the provisions
of the Financial Accounting Standards Board Statement No.  109,
"Accounting for Income Taxes", which requires an asset and
liability approach to calculating deferred income taxes.  The
asset and liability approach requires the recognition of
deferred tax liabilities and assets for the expected future tax
consequences of temporary differences between the carrying
amounts and the tax basis of assets and liabilities.

Use of Estimates

The preparation of financial statements in conformity with
generally accepted accounting principles requires management to
make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure on contingent assets
and liabilities at the date of the financial statements, and the
reported amounts of revenues and expenses during the reporting
period.  Actual results could differ from those estimates.




                                 15


Accounting Method

The Company's financial statements are prepared using the
accrual method of accounting. Revenues are recognized when
earned and expenses when incurred. Fixed assets are stated at
cost. Depreciation and amortization using the straight-line
method for financial reporting purposes and accelerated methods
for income tax purposes.

Earnings per Common Share

The Company adopted Financial Accounting Standards (SFAS) No.
128,"Earnings Per Share," which simplifies the computation of
earnings per share requiring the restatement of all prior
periods.

Basic earnings per share are computed on the basis of the
weighted average number of common shares outstanding during each
year.

Diluted earnings per share are computed on the basis of the
weighted average number of common shares and dilutive securities
outstanding.  Dilutive securities having an anti-dilutive effect
on diluted earnings per share are excluded from the calculation.

Cash and Cash Equivalents


The Company considers all highly liquid debt instruments with a
maturity of three months or less at the time of purchase to be
cash equivalents. Cash and cash equivalents consist of checking
accounts and money market funds.

Fair Value of Financial Instruments

The carrying amounts of financial instruments including cash and
cash equivalents, accounts receivable and payable, accrued and
other current liabilities and current maturities of long-term
debt approximate fair value due to their short maturity.

Recent Accounting Pronouncements

Goodwill and Other Intangible Assets

In July 2001, the Financial Accounting Standards Board issued
Statements of Financial Standards ("SFAS") No. 141, "Business
Combinations" and No. 142, "Goodwill and Other Intangible
Assets". SFAS No. 141 established accounting and reporting
standards for business combinations and eliminates the pooling-
of-interests method of accounting for combinations for those
combinations initiated after July 1, 2001. SFAS No, 141 also
includes new criteria to recognize intangible assets separately
from goodwill. SFAS No. 142 establishes the accounting and
reporting standards from goodwill and intangible lives. Goodwill
and intangibles with indefinite lives will no longer be
amortized, but,
                         16

alternatively will be reviewed periodically for indicators of
impairment. Separate intangible assets that are not deemed to
have an indefinite life will continue to be amortized over their
useful lives. The Company does not anticipate that the adoption
of SFAS No. 141 and SFAS No. 142 will have a significant effect
on its results of operations or financial position.

NOTE 2  -  COMMON STOCK

In 2000, a total of 2,000,000 shares of stock were issued
pursuant to a stock subscription agreement for $0.025 per share
for a total of $5,000 to the original officers and directors.

In 2000, A Form D on Rule S04 offering was declared effective by
the State of Nevada and registered with the Securities and
Exchange Commission to issue 2,000,000 shares at $.05 per share.
The funds will be used for web design and working capital.

NOTE 3  -  RELATED PARTIES

The Company has no significant related party transactions and/or
relationships any individuals or entities.

NOTE 4 - INCOME TAXES

Deferred income taxes arise from temporary differences resulting
from the Company's subsidiary utilizing the cash basis of
accounting for tax purposes and the accrual basis for financial
reporting purposes.  Deferred taxes are classified as current or
non-current, depending on the classification of the assets and
liabilities to which they relate.  Deferred taxes arising from
timing differences that are not related to an asset or liability
are classified as current or non-current depending on the
periods in which the timing differences are expected to reverse.
The Company's previous principal temporary differences relate to
revenue and expenses accrued for financial purposes, which are
not taxable for financial reporting purposes. The Company's
material temporary differences consist of bad debt expense
recorded in the financial statements that is not deductible for
tax purposes and differences in the depreciation expense
calculated for financial statement purposes and tax purposes.

NOTE 5  -  SUBSEQUENT EVENTS

There were no other material subsequent events that have
occurred since the balance sheet date that warrants disclosure
in these financial statements.





                           17












                       SIGNATURES
                       ----------


Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.



                              DrGoodTeeth.Com, Registrant

Dated: March 2, 2002      By:/s/ Dr. Anchana Chayawatana
                              President, Secretary and
                              Director


Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of Registrant and in the capacities and on the dates
indicated:


By: /s/ Dr. Anchana Chayawatana, President, Secretary and
        Director

Dated:  March 2, 2002


By: /s/ Lt. Dr. Sondul Manpiankarn, Treasurer and Director

Dated:  March 2, 2002


By: /s/ Dr. Bancha Luangaram, Vice-President-Marketing and
        Director

Dated:  March 2, 2002


                              18